id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-D-0019-0001,FDA,FDA-1998-D-0019,FDA,Notice,NAD-Notice of Availability of Data,2006-10-12T04:00:00Z,2006,10,2006-10-11T04:00:00Z,2007-10-12T03:59:59Z,2008-05-16T21:17:59Z,,0,0,0900006480563d59
FDA-1998-D-0019-0002,FDA,FDA-1998-D-0019,Guidance,Supporting & Related Material,GDL-Guidance,2006-10-12T04:00:00Z,2006,10,,,2008-05-16T21:17:58Z,,0,0,0900006480563e0c
FDA-1998-D-0019-0003,FDA,FDA-1998-D-0019,Guidance for Industry; Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production,Other,Guidance,2006-10-11T04:00:00Z,2006,10,2006-10-11T04:00:00Z,,2026-01-03T08:31:24Z,,1,0,0900006480563e0f